Antibiotic resistance and the risk of fatal adverse events make it challenging to select an agent.
Cutaneous fungal infections are superficial infections typically involving the skin, hair, and nails.
Recently, consumers have had a renewed interest in probiotics as a treatment option.
Prolonged or continuous infusion of IV beta-lactams has a higher probability of achieving pharmacodynamic goals compared with standard intermittent infusions.
Hepatitis C virus (HCV) remains the leading bloodborne chronic infection in the United States.
Despite the introduction of newer anticoagulants, IV unfractionated heparin is one of the most commonly used parenteral anticoagulants for preventing and treating venous thromboembolism
This technology is an encouraging step forward in drug delivery and formulation design.
It is imperative to recognize the signs of an overdose and administer an antidote quickly.
Personalized medicine allows healthcare professionals to dose patients appropriately.
Given the complexities of current surgery processes, the presence of a pharmacist on the multidisciplinary team is vital to the overall success of the perioperative period.
An increasingly popular pain management strategy is the use of noncontrolled topical agents.
Recent research points to a possible association between vitamin D deficiency and chronic pain.
A donor’s drug profile is one reason for deferral, if there are safety concerns for either donor or recipient.
Historically, cardiac fibrosis has not been a focus for treatment; however, it is now believed that therapy could reduce the progression of heart failure and other cardiovascular diseases.
Adverse effects, primarily cardiovascular in nature, are of concern because of their severe and possibly chronic nature.
Digoxin, a cardiac glycoside, has inotropic effects in addition to effects on cardiac output.
The pathophysiology is not fully understood, rendering pharmacologic treatment difficult.
No true antidote for these agents has been developed, so patients requiring rapid reversal must be appropriately monitored and managed.
Testing for the inflammatory marker CRP may improve risk stratification, especially in intermediate-risk patients.
Endometriosis is a chronic, recurrent disease caused by the extrauterine presence of endometrial tissues.
For more articles, please check our archives.